E. Roussel, “Too good for CARMENA: criteria associated with long systemic therapy free intervals post cytoreductive nephrectomy for metastatic clear cell renal cell carcinoma”, SJU, vol. 54, no. 6, pp. 493–499, Nov. 2020.